Literature DB >> 9573030

Inactivation of the ATM gene in T-cell prolymphocytic leukemias.

D Stoppa-Lyonnet1, J Soulier, A Laugé, H Dastot, R Garand, F Sigaux, M H Stern.   

Abstract

T-cell prolymphocytic leukemia (T-PLL) is a rare form of mature leukemia that occurs both in adults as a sporadic disease and in younger patients suffering an hereditary condition, ataxia telangiectasia (AT). The ATM gene, located in the 11q22-23 chromosomal region, is consistently mutated in AT patients. The strong predisposition of AT patients to develop T-PLL and the high frequency of T-cell leukemias/lymphomas observed in atm-deficient mice, together with the known functions of the ATM protein, led us to evaluate the ATM gene as a potential tumor suppressor gene involved in T-PLL. Paired leukemic and nonleukemic cells were obtained from a series of 15 patients suffering sporadic T-PLLs, allowing loss of heterozygosity (LOH) analysis. LOH of the 11q22-23 region was detected in 10 of these 15 cases (67%). The minimal deleted region was defined as an approximately 2.5 Mb interval that contained the ATM gene. No ATM rearrangement or biallelic deletion was detected by Southern blotting in the T-PLL series. However, in five T-PLLs with LOH of the 11q22-23 region, Western blot analysis showed either undetectable (3 cases) or decreased levels (1 case) of ATM protein, whereas ATM was present at high levels in cases without LOH. The protein truncation test (PTT) was then used to search for mutations in the ATM gene. Four mutations (1 nonsense, 2 aberrant splicings, and 1 missense) were detected in patients with LOH and none in patients without LOH of the region. The acquired character of these ATM mutations was demonstrated in three patients. Altogether, allelic ATM inactivations by large deletions or mutations were found in approximately two thirds of T-PLL. ATM is thus a tumor suppressor gene whose inactivation is a key event in the development of T-cell prolymphocytic leukemias.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573030

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

1.  Mantle cell lymphoma is characterized by inactivation of the ATM gene.

Authors:  C Schaffner; I Idler; S Stilgenbauer; H Döhner; P Lichter
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 2.  T-cell prolymphocytic leukemia.

Authors:  Claire E Dearden
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

3.  Molecular allelokaryotyping of T-cell prolymphocytic leukemia cells with high density single nucleotide polymorphism arrays identifies novel common genomic lesions and acquired uniparental disomy.

Authors:  Daniel Nowak; Emilie Le Toriellec; Marc-Henri Stern; Norihiko Kawamata; Tadayuki Akagi; Martin J Dyer; Wolf-Karsten Hofmann; Seishi Ogawa; H Phillip Koeffler
Journal:  Haematologica       Date:  2009-03-10       Impact factor: 9.941

4.  Redundant and nonredundant functions of ATM and H2AX in αβ T-lineage lymphocytes.

Authors:  Bu Yin; Baeck-Seung Lee; Katherine S Yang-Iott; Barry P Sleckman; Craig H Bassing
Journal:  J Immunol       Date:  2012-06-22       Impact factor: 5.422

Review 5.  Molecular pathology of ataxia telangiectasia.

Authors:  A M R Taylor; P J Byrd
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

Review 6.  ATM, radiation, and the risk of second primary breast cancer.

Authors:  Jonine L Bernstein; Patrick Concannon
Journal:  Int J Radiat Biol       Date:  2017-07-27       Impact factor: 2.694

7.  T-cell prolymphocytic leukemia in an adolescent with ataxia-telangiectasia: novel approach with a JAK3 inhibitor (tofacitinib).

Authors:  Geling Li; Emily Waite; Julie Wolfson
Journal:  Blood Adv       Date:  2017-12-18

8.  Importance of ATM gene as a susceptible trait: predisposition role of D1853N polymorphism in breast cancer.

Authors:  Parvin Mehdipour; Marzieh Mahdavi; Javad Mohammadi-Asl; Morteza Atri
Journal:  Med Oncol       Date:  2010-04-16       Impact factor: 3.064

9.  Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.

Authors:  Lori A Ehrlich; Katherine Yang-Iott; Craig H Bassing
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

10.  Occurrence of TRGV-BJ hybrid gene in SV40-transformed fibroblast cell lines.

Authors:  L P G D'Arce; C L Bassi; A L Fachin; G A S Passos; E T Sakamoto-Hojo
Journal:  Genetica       Date:  2009-01-14       Impact factor: 1.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.